The rationale for differing national recommendations for the treatment of hypertension

American Journal of Hypertension

Volumn 11, Issue 6 II SUPPL., 1998, Pages

  Ramsay, Lawrence E ^a   Wallis, Erica J ^a   Yeo, Wilfred W ^a   Jackson, Peter R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Absolute cardiovascular risk; Anti0hypertensive treatment; Guidelines; Randomized controlled trials

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG CONTRAINDICATION; DRUG INDICATION; HYPERTENSION; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0031854291     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(98)00063-6     Document Type: Review

References (44)

1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC-V). Arch Intern Med 1993;153:154-183.
2. WHO-ISH Guidelines Subcommittee: Guidelines for the management of mild hypertension: memorandum from a World Health Organisation/International Society of Hypertension meeting. J Hypertens 1993;11:905-918.
3. Sever P, Beevers G, Bulpitt C, et al: Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993;306:983-987.
4. Jackson R, Barham P, Bills J, et al: Management of raised blood pressure in New Zealand: a discussion document. Br Med J 1993;307:107-110.
5. Ministry of Health: Guidelines for the Management of Mildly Raised Blood Pressure in New Zealand. Core Services Committee, Ministry of Health; Wellington, New Zealand, 1995.
6. Lever AF, Ramsay LE. Treatment of hypertension in the elderly. J Hypertens 1995;13:571-579.
7. Cook RJ, Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995;310:452-454.
8. Amery A, Birkenhäger, Brixko P, et al, on behalf of the European Working Party on High Blood Pressure in the Elderly: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;i:1349-1354.
9. Ramsay LE, Haq IU, Yeo WW, et al: Interpretation of prospective trials in hypertension: do treatment guidelines accurately reflect current evidence? J Hypertens 1996;14(suppl 5):S187-S194.
10. Medical Research Council Working Party: MRC trial of mild hypertension: principal results. Br Med J 1985;291: 97-104.
11. Ramsay LE: Mild hypertension: treat patients, not populations. J Hypertens 1985;3:449-455.
12. National High Blood Pressure Education Program: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health, Bethesda, MD, Publication No. 98-4080, 1997.
13. Joint National Committee: 1988 report of the JNC on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1988;148:1023-1038.
14. Swales JD, Ramsay LE, Coope JR, et al: Treating mild hypertension. Br Med J 1989;298:694-698.
15. Guidelines Sub-Committee: 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989;7:689-693.
16. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
17. Peart S, Brennan PJ, Broughton P, et al, on behalf of the MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
18. The Treatment of Mild Hypertension Research Group: The treatment of mild hypertension study: a randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991;151:1413-1423.
19. Neaton JD, Grimm RH, Prineas RJ, et al, for the Treatment of Mild Hypertension Study Group: Treatment of mild hypertension study: final results. JAMA 1993;270: 713-724.
20. Reader R, Bauer GE, Doyle AE, et al, on behalf of the Management Committee: The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980;i:1261-1267.
21. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2571.
22. Hypertension Detection and Follow-up Program Cooperative Group: The effect of treatment on mortality in "mild" hypertension: results of the Hypertension Detection and Follow-up Program. N Engl J Med 1982; 307:976-980.
23. Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982;248: 1465-1477.
24. Ramsay LE: The Hypertension Detection and Follow-up Program 17 years on. JAMA 1997;277:167-170.
25. Langford HG, Stamler J, Wassertheil-Smoller S, et al: All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog Cardiovasc Dis 1986;29(suppl 1):29-54.
26. Moser M, Gifford RW: Why less severe degrees of hypertension should be treated. J Hypertens 1985;3: 437-447.
27. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. III. Reductions in stroke incidence among persons with high blood pressure. JAMA 1982;247:633-638.
28. Hypertension Detection and Follow-up Program Cooperative Group: Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris: 5-year findings of the Hypertension Detection and Follow-up Program. Hypertension 1984;6(suppl 1):1-198-1-206.
29. Maxwell MH, Ford CE: Cardiovascular morbidity and mortality in HDFP patients 50-69 years old at entry. J Cardiovasc Pharmacol 1985;7(suppl 2):S5-S9.
30. Borhani NO, Blaufox D, Oberman A, et al: Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis 1986;29(suppl 1):55-62.
31. Rose G, McCartney P, Reid DD: Self administration of questionnaire on chest pain and intermittent claudication. Br J Soc Med 1977;31:42-48.
32. Bennett N, Dodd T, Flatley J, et al, for the Office of Population and Censuses Surveys: Health Survey for England 1993 HMSO, London, 1995.
33. Johannesson M: Cost-effectiveness of hypertension treatment in Sweden. PharmacoEconomics 1995;7:242-250.
34. Collins R, Peto R: Antihypertensive drug therapy: effects on stroke and coronary heart disease, in: Swales JD (ed): Textbook of Hypertension. Blackwell Scientific, Oxford, 1992, pp 1-13.
35. Hoes AW, Grobbee DE, Lubson J: Does drug treatment improve survival? Reconciling the trials in mild to moderate hypertension. J Hypertens 1995;13:805-811.
36. Egger M, Davey Smith G: Risks and benefits of treating mild hypertension: a misleading meta-analysis? J Hypertens 1995;13:813-815.
37. Freis ED: Should mild hypertension be treated? N Engl J Med 1982;307:306-309.
38. Lefebvre R, Hursey K, Carleton R: Labeling of participants in hypertension screening programs: implications for blood cholesterol screenings. Arch Intern Med 1988;148:1993-1997.
39. Davies SJC, Ghahramani P, Noble W, et al: Panic attacks and panic disorder more common in hypertensive than normal subjects: a case control study (abst). J Hypertens 1997;15(suppl 4);S51.
40. Davies SJC, Ghahramani P, Jackson PR, et al: Panic disorder, anxiety, and depression in resistant hypertension - a case control study. J Hypertens 1997;15:1077-1082.
41. Kaplan NM: Anxiety induced hyperventilation. Arch Intern Med 1997;157:945-948.
42. Madhavan S, Alderman MH: The potential effect of blood pressure reduction on cardiovascular disease. Arch Intern Med 1981;141:1583-1586.
43. Simpson FO: Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk. J Hypertens 1996;14:683-689.
44. Grover SA, Lowensteyn I, Esrey KL, et al: Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. Br Med J 1995;310:975-978.